Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Paul Eggleton, Edwin Bremer, Elzbieta Dudek & Marek Michalak. (2016) Calreticulin, a therapeutic target?. Expert Opinion on Therapeutic Targets 20:9, pages 1137-1147.
Read now
Read now
Sofia R Gameiro, Andressa Ardiani, Anna Kwilas & James W Hodge. (2014) Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens. OncoImmunology 3:5.
Read now
Read now
Articles from other publishers (26)
Kellsye P. Fabian, Joshua T. Kowalczyk, Sandy T. Reynolds & James W. Hodge. (2022) Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation. Cells 11:23, pages 3826.
Crossref
Crossref
Kellsye P. Fabian, Benjamin Wolfson & James W. Hodge. (2021) From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment. Frontiers in Oncology 11.
Crossref
Crossref
Benjamin Wolfson, Michelle R Padget, Jeffrey Schlom & James W Hodge. (2021) Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing. Journal for ImmunoTherapy of Cancer 9:7, pages e002258.
Crossref
Crossref
Benjamin Wolfson & James W. Hodge. (2021)
Next Generation Therapeutic Strateg‐Es:
Evolving
cancer immunotherapy through agents that
Engage
,
Expand
and
Enable
the anti‐tumor immune response
. ImmunoMedicine 1:1.
Crossref
Crossref
S. Elizabeth Franks, Benjamin Wolfson & James W. Hodge. (2020) Natural Born Killers: NK Cells in Cancer Therapy. Cancers 12:8, pages 2131.
Crossref
Crossref
Walid S. Kamoun, Anne-Sophie Dugast, James J. Suchy, Stephanie Grabow, Ross B. Fulton, James F. Sampson, Lia Luus, Michael Santiago, Alexander Koshkaryev, Gang Sun, Vasileios Askoxylakis, Eric Tam, Zhaohua Richard Huang, Daryl C. Drummond & Andrew J. Sawyer. (2020) Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models. Molecular Cancer Therapeutics 19:1, pages 270-281.
Crossref
Crossref
Dustin Boothe, Joseph W. Clyde, Michael Christensen, Shiven B. Patel & Shane Lloyd. (2018) A comprehensive analysis of clinical trials including both immunotherapy and radiation therapy. Journal of Radiation Oncology 7:3, pages 223-232.
Crossref
Crossref
Jennifer Moy & Robert L. Ferris. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
365
396
.
Adam Brufsky. (2017) nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings. Experimental Hematology & Oncology 6:1.
Crossref
Crossref
Jennifer D. Moy, Jessica M. Moskovitz & Robert L. Ferris. (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. European Journal of Cancer 76, pages 152-166.
Crossref
Crossref
Julie E. Bauman, Ezra Cohen, Robert L. Ferris, David J. Adelstein, David M. Brizel, John A. Ridge, Brian O'Sullivan, Barbara A. Burtness, Lisa H. Butterfield, William E. Carson, Mary L. Disis, Bernard A. Fox, Thomas F. Gajewski, Maura L. Gillison, James W. Hodge, Quynh-Thu Le, David Raben, Scott E. Strome, Jean Lynn & Shakun Malik. (2017) Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer 123:7, pages 1259-1271.
Crossref
Crossref
Jeffery Schlom, James L. Gulley & James W. Hodge. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
22
.
Chris Heery, Anteneh Tesfaye, Benjamin Weinberg & John Marshall. 2017. Immunotherapy for Gastrointestinal Cancer. Immunotherapy for Gastrointestinal Cancer
47
78
.
Anthony S. Malamas, Sofia R. Gameiro, Karin M. Knudson & James W. Hodge. (2016) Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas’ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation. Oncotarget 7:52, pages 86937-86947.
Crossref
Crossref
Christopher R. Heery, Ravi A. Madan, Mark N. Stein, Walter M. Stadler, Robert S. Di Paola, Myrna Rauckhorst, Seth M. Steinberg, Jennifer L. Marté, Clara C. Chen, Italia Grenga, Renee N. Donahue, Caroline Jochems, William L. Dahut, Jeffrey Schlom & James L. Gulley. (2016) Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial. Oncotarget 7:42, pages 69014-69023.
Crossref
Crossref
Christopher R. Heery. (2016) Chordoma: The Quest for Better Treatment Options. Oncology and Therapy 4:1, pages 35-51.
Crossref
Crossref
Anna R. Kwilas, Andressa Ardiani, Sofia R. Gameiro, Jacob Richards, Ashley B. Hall & James W. Hodge. (2016) Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin. Oncotarget 7:17, pages 23498-23511.
Crossref
Crossref
Naoto T. Ueno & Eleftherios P. Mamounas. (2016) Neoadjuvant nab-paclitaxel in the treatment of breast cancer. Breast Cancer Research and Treatment 156:3, pages 427-440.
Crossref
Crossref
Anita Kumari, Samantha S Simon, Tomika D Moody & Charlie Garnett-Benson. (2016) Immunomodulatory effects of radiation: what is next for cancer therapy?. Future Oncology 12:2, pages 239-256.
Crossref
Crossref
Italia Grenga, Anna R. Kwilas, Renee N. Donahue, Benedetto Farsaci & James W. Hodge. (2015) Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Crossref
Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, Jennifer L. Marté, Renee N. Donahue, Italia Grenga, Timothy C. Rodell, William Dahut, Philip M. Arlen, Ravi A. Madan, Jeffrey Schlom & James L. Gulley. (2015) Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury. Cancer Immunology Research 3:11, pages 1248-1256.
Crossref
Crossref
Claudia Urueña, Alejandra Gomez, Tito Sandoval, John Hernandez, Shaoping Li, Alfonso Barreto & Susana Fiorentino. (2015) Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model. Integrative Cancer Therapies 14:5, pages 468-483.
Crossref
Crossref
WenJia Wang, SiHao Qin & Lei Zhao. (2015) Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation. Biomedicine & Pharmacotherapy 69, pages 18-23.
Crossref
Crossref
Fei Yang, Yinxiang Wei, Zhijian Cai, Lei Yu, Lingling Jiang, Chengyan Zhang, Huanmiao Yan, Qingqing Wang, Xuetao Cao, Tingbo Liang & Jianli Wang. (2014) Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling. Cellular & Molecular Immunology 12:1, pages 66-76.
Crossref
Crossref
Charlie Garnett-Benson, James W. Hodge & Sofia R. Gameiro. (2015) Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities. Seminars in Radiation Oncology 25:1, pages 46-53.
Crossref
Crossref
Kwong Y. Tsang, Caroline Jochems & Jeffrey Schlom. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
1
27
.